At the same time, ARC activates or inhibits neuropeptide Y (NPY) and agouti-related protein (AgRP) to control feeding behavior and energy metabolism [13], which is closely related to the onset of obesity and type 2 diabetes [14]. Here, AGRP is linked to obesity disorder.